Search Results - "DE MIGUEL, Dunia"

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry by Bernal, Teresa, Moreno, Ainhoa Fernández, de LaIglesia, Almudena, Benavente, Celina, García‐Noblejas, Ana, Belmonte, Daniel García, Riaza, Rosalía, Salamero, Olga, Foncillas, Maria Angeles, Roldán, Alicia, Concepción, Víctor Noriega, González, Laura Llorente, Bergua Burgués, Juan Miguel, Lorente de Uña, Soraya, Rodríguez‐Macías, Gabriela, de la Fuente Burguera, Adolfo, García Pérez, Maria José, López‐Lorenzo, Jose Luis, Martínez, Pilar, Aláez, Concepción, Callejas, Marta, Martínez‐Chamorro, Carmen, Roca, José Rifón, Barciela, Lourdes Amador, Mena Durán, Armando V., Gómez Correcha, Karoll, Lavilla Rubira, Esperanza, Amigo, María Luz, Vall‐llovera, Ferran, Garrido, Ana, García‐Fortes, María, de Miguel Llorente, Dunia, Leonardo, Anastasia Aules, Cervero, Carlos, Jordá, Rosa Coll, Pérez‐Encinas, Manuel M., Zarzuela, Marta Polo, Figuera, Angela, Rad, Guillermo, Martínez‐Cuadrón, David, Montesinos, Pau

“…Background CPX‐351 is approved for the treatment of therapy related acute myeloid leukemia (t‐AML) and AML with myelodysplastic related changes (MRC‐AML). The…”
Get full text

Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome by Subirá, Dolores, Alhan, Canan, Oelschlaegel, Uta, Porwit, Anna, Psarra, Katherina, Westers, Theresia M., Golbano, Nuria, Nilsson, Lars, van de Loosdrecht, Arjan A, de Miguel, Dunia

“…5-Azacitidine (AZA) therapy is used in high-risk myelodysplastic syndrome (MDS) patients who often show abnormalities in their immunophenotype. We explored the…”
Get full text

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience by Labrador, Jorge, Saiz-Rodríguez, Miriam, de Miguel, Dunia, de Laiglesia, Almudena, Rodríguez-Medina, Carlos, Vidriales, María Belén, Pérez-Encinas, Manuel, Sánchez-Sánchez, María José, Cuello, Rebeca, Roldán-Pérez, Alicia, Vives, Susana, Benzo-Callejo, Gonzalo, Colorado, Mercedes, García-Fortes, María, Sayas, María José, Olivier, Carmen, Recio, Isabel, Conde-Royo, Diego, Bienert-García, Álvaro, Vahi, María, Muñoz-García, Carmen, Seri-Merino, Cristina, Tormo, Mar, Vall-Llovera, Ferran, Foncillas, María-Ángeles, Martínez-Cuadrón, David, Sanz, Miguel Ángel, Montesinos, Pau

“…The effectiveness of venetoclax (VEN) in relapsed or refractory acute myeloid leukemia (RR-AML) has not been well established. This retrospective, multicenter,…”
Get full text

Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia by García-Delgado, Regina, de Miguel, Dunia, Bailén, Alicia, González, José Ramón, Bargay, Joan, Falantes, José F, Andreu, Rafael, Ramos, Fernando, Tormo, Mar, Brunet, Salut, Figueredo, Antonio, Casaño, Javier, Medina, Ángeles, Badiella, Llorenç, Jurado, Antonio Fernández, Sanz, Guillermo

“…Abstract We investigated the effectiveness and tolerability of azacitidine in patients with World Health Organization-defined myelodysplastic syndromes, or…”
Get full text

PB2703: ISA‐KD IN NOT TRANSPLANT CANDIDATES RRMM. EXPERIENCE IN REAL LIFE by Llorente, Dunia De Miguel, Lopez, Nuria Golbano, Alonso, Rocio Perez, Ramo, Alejandro Vazquez, Montero, Ana Belen Santos, Lopez, Irene Nuevo, Argumanez, Marta Mora, Garcia, Helga Guillen, Perez, Angela Gil

Get full text

PB2270: PROGNOSTIC VALUE OF INTERIM POSITRON EMISSION TOMOGRAPHY IN HIGH‐TUMOR‐BURDEN FOLLICULAR LYMPHOMA by Argumánez, Marta Mora, Perez, Rocio, Padilla, Beatriz Alvarez, López, María Irene Nuevo, Gil, Angela, Pérez, Dolores Subirá, Montero, Ana Belén Santos, Golbano, Nuria, García, Helga Guillén, Ramo, Alejandro Vazquez, Martín, Sonia Herrero, Moreno, Laura, Juanis, Jaime Arbeteta, Sanz, María Dolores Morales, Llorente, Dunia De Miguel

Get full text

PB2628: EXPERIENCE AT THE GUADALAJARA UNIVERSITY HOSPITAL (SPAIN) IN FETAL AND NEONATAL ALLOINMUNE THROMBOCYTOPENIA (FNAIT) DURING EIGHT YEARS by López, María Irene Nuevo, Argumanez, Marta Mora, Sanz, Mª Dolores Morales, Alonso, Rocio Perez, Padilla, Beatriz Álvarez, Pérez, Ángela Gil, García, Helga Guillén, Ramo, Alejandro Vazquez, Fernandez, Berta Mercedes Michael, López, Nuria Golbano, Herrero, Sonia, Juanis, Jaime Arbeteta, Llorente, Dunia de Miguel

Get full text

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study by Dachs, Laura Rosiñol, Gaisán, Carmen Montes, Bustamante, Gabriela, López, Sebastián Garzón, García, Esther González, Persona, Ernesto Pérez, González-Calle, Verónica, Auzmendi, Maialen Sirvent, Pérez, José Maria Arguiñano, González Montes, Yolanda, Ríos Tamayo, Rafael, de Miguel Llorente, Dunia, Bernal, Luis Palomera, Mayol, Antonia Sampol, Caro, Carmen Couto, Grande, Marta, Fernández-Nistal, Alonso, Naves, Andrea, Miguel, Enrique M Ocio San

“…We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific…”
Get full text

Impact of early palliative care intervention in autologous bone marrow transplantation: feasibility of a multicentric study by Argüello-Marina, María, Callejas-Charavía, Marta, Merchán-Muñoz, Beatriz, Gainza-Miranda, Daniel, Rico-Zampetti, Agustina, Pérez-Maganto, Raquel, Ruiz-Ares, Gustavo, García-Ramírez, Patricia, de Miguel-Llorente, Dunia, García-Suárez, Julio

“…This prospective multicentre study evaluates the impact of Palliative Care Unit (PCU) intervention (Experimental Group, EG), during autologous hematopoietic…”
Get full text

Changes in the natural history of progressive multifocal leukoencephalopathy in HIV‐negative lymphoproliferative disorders: Impact of novel therapies by García‐Suárez, Julio, de Miguel, Dunia, Krsnik, Isabel, Bañas, Helena, Arribas, Ignacio, Burgaleta, Carmen

“…The aims of this study were to evaluate the clinical characteristics of HIV‐negative patients affected by lymphoproliferative disorders (LPD) who developed…”
Get full text

Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score by Falantes, Jose, Delgado, Regina García, Calderón-Cabrera, Cristina, Márquez-Malaver, Francisco J, Valcarcel, David, de Miguel, Dunia, Bailén, Alicia, Bargay, Joan, Bernal, Teresa, González-Porras, Jose R, Tormo, Mar, Ramos, Fernando, Andreu, Rafael, Xicoy, Blanca, Nomdedeu, Benet, Brunet, Salut, Sánchez, Joaquín, Jurado, Antonio Fernández, Bonanad, Santiago, Pérez-Simón, Jose Antonio, Sanz, Guillermo

“…Highlights • Two scores identify lower-risk patients with survival similar to high-risk patients. • Achieving response to azacitidine in these patients appears…”
Get full text

PB2491: LANGERHANS CELL HISTIOCYTOSIS (LCH) IN THE MAXILLOFACIAL AREA IN ADULT. COMPLETE REMISSION WITH CLADRIBINE. CASE REPORT AND REVIEW by De Miguel Llorente, Dunia, Golbano López, Nuria, Belen Santos Montero, Ana, Alonso, Rocio Perez, Vazquez Ramo, Alejandro, Guillen García, Helga, Gil Perez, Angela, Mora Argumanez, Marta, Nuevo Lopez, Irene

Get full text

Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs by de Miguel, Dunia, García-Suárez, Julio, Martín, Yolanda, Gil-Fernández, Juan José, Burgaleta, Carmen

Get full text

Elderly haematological patients with chemotherapy‐induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk‐adapted therapy by García‐Suárez, Julio, Krsnik, Isabel, Reyes, Eduardo, De Miguel, Dunia, Hernanz, Nuria, Barr‐Alí, Mohamed, Burgaleta, Carmen

“…We prospectively evaluated 131 consecutive episodes of fever and chemotherapy‐induced neutropenia in 85 adults with haematological malignancies to determine…”
Get full text

Risk factors and outcome of COVID-19 in patients with hematological malignancies by Piñana, José Luis, Martino, Rodrigo, García-García, Irene, Parody, Rocío, Morales, María Dolores, Benzo, Gonzalo, Gómez-Catalan, Irene, Coll, Rosa, De La Fuente, Ignacio, Luna, Alejandro, Merchán, Beatriz, Chinea, Anabelle, de Miguel, Dunia, Serrano, Ana, Pérez, Carmen, Diaz, Carola, Lopez, José Luis, Saez, Adolfo Jesús, Bailen, Rebeca, Zudaire, Teresa, Martínez, Diana, Jurado, Manuel, Calbacho, María, Vázquez, Lourdes, Garcia-Cadenas, Irene, Fox, Laura, Pimentel, Ana I, Bautista, Guiomar, Nieto, Agustin, Fernandez, Pascual, Vallejo, Juan Carlos, Solano, Carlos, Valero, Marta, Espigado, Ildefonso, Saldaña, Raquel, Sisinni, Luisa, Ribera, Josep Maria, Jimenez, Maria Jose, Trabazo, Maria, Gonzalez-Vicent, Marta, Fernández, Noemí, Talarn, Carme, Montoya, Maria Carmen, Cedillo, Angel, Sureda, Anna

“…Prognostic factors of poor outcome in patients with hematological malignancies and COVID-19 are poorly defined. This was a Spanish transplant group and cell…”
Get full text

Spontaneous gas gangrene in malignant lymphoma: An underreported complication? by García‐Suárez, Julio, Miguel, Dunia de, Krsnik, Isabel, Barr‐Alí, Mohammed, Hernanz, Nuria, Burgaleta, Carmen

“…We report a case of spontaneous gas gangrene (SGG), the most rapidly progressive form of clostridial infection, in a patient with non‐Hodgkin's lymphoma (NHL)…”
Get full text

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma by Lasa, Marta, Notarfranchi, Laura, Agullo, Cristina, Gonzalez, Carmen, Castro, Sergio, Perez, Jose J, Burgos, Leire, Guerrero, Camila, Calasanz, Maria Jose, Flores-Montero, Juan, Oriol, Albert, Bargay, Joan, Rios, Rafael, Cabañas, Valentin, Cabrera, Carmen, Martinez-Martinez, Rafael, Encinas, Cristina, De Arriba, Felipe, Hernandez, Miguel-Teodoro, Palomera, Luis, Orfao, Alberto, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, San-Miguel, Jesus, Lahuerta, Juan Jose, Rosiñol, Laura, Blade, Joan, Cedena, Maria Teresa, Puig, Noemi, Paiva, Bruno

“…JCO In multiple myeloma (MM), measurable residual disease (MRD) is assessed in bone marrow (BM). However, less invasive evaluation of peripheral residual…”
Get full text

Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study by Ocio, Enrique M., Montes-Gaisán, Carmen, Bustamante, Gabriela, Garzón, Sebastián, González, Esther, Pérez-Persona, Ernesto, González-Calle, Verónica, Sirvent, Maialen, Arguiñano, José M., González, Yolanda, Ríos, Rafael, de Miguel, Dunia, Grande, Marta, Fernández-Nistal, Alonso, Naves, Andrea, Rosiñol, Laura

“…Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real-world data regarding the utilization…”
Get full text

Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study by Ocio, Enrique M., Montes-Gaisán, Carmen, Bustamante, Gabriela, Garzón, Sebastián, González, Esther, Pérez, Ernesto, Sirvent, Maialen, Arguiñano, José María, González, Yolanda, Ríos, Rafael, de Miguel, Dunia, Grande, Marta, Fernández, Alonso, Naves, Andrea, Rosiñol, Laura

“…Treatment of relapsed and/or refractory multiple myeloma (RRMM) should be established based on multiple factors, including previous treatment and the…”
Get full text

Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain by Hernández-Rivas, José-Ángel, Arnao, Mario, Arguiñano Pérez, José Maria, Rubio, Araceli, García, Esther Gónzalez, de Miguel, Dunia, Cherepanov, Dasha, Romanus, Dorothy, Verleger, Katharina, Johnson, Courtney, Corman, Shelby L, Grande, Marta, Persona, Ernesto Pérez

“…To describe treatment patterns and outcomes in nontransplant newly diagnosed multiple myeloma (NDMM) patients in Spain. This retrospective study included two…”
Get full text